Life Sciences
Toxicology Services
Trinity Consultants’ SafeBridge group is the premier environmental health and safety resource for the pharmaceutical research and manufacturing industries. We set the definitive standard for the toxicological evaluation and hazard assessment of drugs and drug products, ensuring that the products are safe and the people contributing to their development are protected.
ON-DEMAND TRAINING
Evaluating the Hazards of Pharmaceuticals: Basic Concepts
How Else We Can Help
Related Services
Potent Compound Safety Certification
A groundbreaking tool for drug innovators and contract manufacturing organizations.Industrial Hygiene
Extensive industrial hygiene support for the life sciences sector.Industrial Hygiene Analytical Laboratory
AIHA-Accredited Analytical Laboratory for Method Development and Sample AnalysisHazard Communications and GHS Services
Expertise in chemical hazard classification, preparation of SDSs, and compliance with global hazard communication regulations.Our Results
Featured Projects
Trinity's SafeBridge Group Identifies Chloracne Source in Research Lab
SafeBridge investigated an outbreak of chloracne in a discovery lab at a top 5 pharma company, determined the novel compound responsible for the outbreak and recommended a safe course of remediation.Pharmaceutical Leader Evaluates Safety and Quality of New Transdermal Patch
SafeBridge partnered with a global pharma company to design and perform extractables and leachables (E&L) testing and provide toxicological assessment of the results to assess the product’s safety and quality.Service Specifics
Toxicology Services
Hazard Assessment and Risk Communication
Occupational Exposure Limits (OELs)
Health-Based Exposure Limits (HBELs)
- Permitted Daily Exposures (PDEs)
- Acceptable Daily Exposures (ADEs)
Occupational Health Categorization and Banding
Safety Data Sheet Development
Extractables and Leachables (E&L) Evaluation
SafeBridge toxicologists evaluate the potential for chemicals to leach out of product packaging and processing components, setting acceptable limits for these potential contaminants in drug products. Where further testing is required to accurately evaluate risk, our team designs and oversees testing, assuring scientific rigor and presenting findings in reports that are designed to facilitate conclusive FDA reviews.
Environmental Risk Assessments
SafeBridge's experienced scientists prepare environmental risk assessments for investigational new drugs (IND) or new drug application (NDA) submissions to FDA, or marketing authorization applications (MAA) to the European Medicines Agency (EMA), according to current guidelines.